Connect with us

Drugs

#Brexit with no deal risks chaos in drug supply, report warns

SHARE:

Published

9 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Crashing out of the European Union without a deal would cause major problems for Britain’s health service and risk “chaotic disruption” to medicine supplies, according to a report on Tuesday (7 November).

The Nuffield Trust, an independent health charity, also warned that Brexit without a deal on future relations with the EU would lead to worsening staff shortages in the National Health Service (NHS).

And it could create particular problems for healthcare in Northern Ireland, where treatment programmes for some rare and serious diseases are designed to work across the entire island of Ireland.

“A scenario where the UK leaves without any deal would cause extensive problems for the NHS. It would risk a chaotic disruption to supplies of medical products, and a rise in prices that would push hospitals deeper into deficit,” the report stated.

“Many different parts of EU law and EU institutions play an important role in enabling care to be delivered to the standards we see today. Suddenly ending them with no replacement would do serious damage to an already strained British NHS.”

The warning chimes with concerns from pharmaceutical companies, which are already drawing up plans to protect supply chains.

Stringent medicine regulations mean manufacturers face multiple Brexit uncertainties, such as the potential need to retest drugs shipped across borders and transfer product licences to different jurisdictions.

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending